Commentary on an article by Rick Delamarter, MD, et al.: "Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level degenerative lumbar disc disease. Results at twenty-four months". [electronic resource]
Producer: 20110726Description: e41 p. digitalISSN:- 1535-1386
- Arthroplasty, Replacement -- instrumentation
- Device Approval
- Disability Evaluation
- Humans
- Intervertebral Disc
- Intervertebral Disc Degeneration -- complications
- Low Back Pain -- etiology
- Lumbar Vertebrae -- surgery
- Multicenter Studies as Topic
- Patient Satisfaction
- Postoperative Complications
- Prostheses and Implants
- Prosthesis Design
- Randomized Controlled Trials as Topic
- Range of Motion, Articular
- Recovery of Function
- Spinal Fusion -- instrumentation
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Comment; Journal Article
There are no comments on this title.
Log in to your account to post a comment.